KLF4K409Q–mutated meningiomas show enhanced hypoxia signaling and respond to mTORC1 inhibitor treatment

[1]  Mark W. Youngblood,et al.  Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas. , 2020, Journal of neurosurgery.

[2]  T. Acker,et al.  HIF1α Suppresses Tumor Cell Proliferation through Inhibition of Aspartate Biosynthesis. , 2019, Cell reports.

[3]  P. Brastianos,et al.  Advances in meningioma genetics: novel therapeutic opportunities , 2018, Nature Reviews Neurology.

[4]  C. Hartmann,et al.  Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence , 2017, Neuro-oncology.

[5]  Xuanchun Wang,et al.  KLF4 is a tumor suppressor in anaplastic meningioma stem-like cells and human meningiomas , 2017, Journal of molecular cell biology.

[6]  Qiaojun He,et al.  Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells , 2017, Stem cell reports.

[7]  M. Sanson,et al.  SMO mutation status defines a distinct and frequent molecular subgroup in olfactory groove meningiomas , 2017, Neuro-oncology.

[8]  M. Weller,et al.  EANO guidelines for the diagnosis and treatment of meningiomas. , 2016, The Lancet. Oncology.

[9]  L. Pfeffer,et al.  KLF4 Promotes Angiogenesis by Activating VEGF Signaling in Human Retinal Microvascular Endothelial Cells , 2015, PloS one.

[10]  Wei Li,et al.  HIF-1α pathway: role, regulation and intervention for cancer therapy , 2015, Acta pharmaceutica Sinica. B.

[11]  Steven L Salzberg,et al.  HISAT: a fast spliced aligner with low memory requirements , 2015, Nature Methods.

[12]  Wei Shi,et al.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..

[13]  Murim Choi,et al.  Genomic Analysis of Non-NF2 Meningiomas Reveals Mutations in TRAF7, KLF4, AKT1, and SMO , 2013, Science.

[14]  F. Angenstein,et al.  mTORC1 Inhibitors Suppress Meningioma Growth in Mouse Models , 2013, Clinical Cancer Research.

[15]  Roland Eils,et al.  Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations , 2013, Acta Neuropathologica.

[16]  H. Steiger,et al.  Malignant potential of skull base versus non-skull base meningiomas: clinical series of 1,663 cases , 2013, Acta Neurochirurgica.

[17]  J. Barnholtz-Sloan,et al.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.

[18]  W. Rathmell,et al.  Regulation of KLF4 turnover reveals an unexpected tissue-specific role of pVHL in tumorigenesis. , 2012, Molecular cell.

[19]  Brian Keith,et al.  HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression , 2011, Nature Reviews Cancer.

[20]  Q. Mao,et al.  Expression of aquaporin-4 in human supratentorial meningiomas with peritumoral brain edema and correlation of VEGF with edema formation. , 2011, Genetics and molecular research : GMR.

[21]  C. Cole,et al.  COSMIC: the catalogue of somatic mutations in cancer , 2011, Genome Biology.

[22]  D. Cho,et al.  mTOR inhibitors in renal cell carcinoma. , 2011, Therapy.

[23]  C. Mawrin,et al.  Cytotoxic effects of statins and thiazolidinediones on meningioma cells , 2011, Journal of Neuro-Oncology.

[24]  Fang Yu,et al.  Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion , 2010, Oncogene.

[25]  M. Westphal,et al.  Secretory meningiomas: a benign subgroup causing life-threatening complications. , 2009, Neuro-oncology.

[26]  Mark D. Robinson,et al.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..

[27]  M. Boakye,et al.  Craniotomy for resection of meningioma in the elderly: a multicentre, prospective analysis from the National Surgical Quality Improvement Program , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[28]  Deepak Srivastava,et al.  miR-145 and miR-143 Regulate Smooth Muscle Cell Fate Decisions , 2009, Nature.

[29]  H. Iwase,et al.  Hypoxia-inducible factor 1α is closely linked to an aggressive phenotype in breast cancer , 2008, Breast Cancer Research and Treatment.

[30]  Shicai Wang,et al.  COSMIC: the Catalogue Of Somatic Mutations In Cancer , 2018, Nucleic Acids Res..

[31]  P. Evans,et al.  Roles of Kruppel-like factor 4 in normal homeostasis, cancer and stem cells , 2008 .

[32]  David B Seligson,et al.  Hypoxia-Inducible Factor 1α in Clear Cell Renal Cell Carcinoma , 2007, Clinical Cancer Research.

[33]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[34]  P. Chomczyński,et al.  The single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction: twenty-something years on , 2006, Nature Protocols.

[35]  R. DePinho,et al.  Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: assessment of an oral agent that stimulates erythropoietin production. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[36]  R. Bernards,et al.  The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene , 2005, Nature Cell Biology.

[37]  P. Carmeliet,et al.  Genetic evidence for a tumor suppressor role of HIF-2alpha. , 2005, Cancer cell.

[38]  T. Tamiya,et al.  The relationship between peritumoral brain edema and the expression of vascular endothelial growth factor and its receptors in intracranial meningiomas , 2004, Journal of Neuro-Oncology.

[39]  P. Korkolopoulou,et al.  Hypoxia‐inducible factor 1α/vascular endothelial growth factor axis in astrocytomas. Associations with microvessel morphometry, proliferation and prognosis , 2004, Neuropathology and applied neurobiology.

[40]  Elaine Fuchs,et al.  Klf4 is a transcription factor required for establishing the barrier function of the skin , 1999, Nature Genetics.

[41]  J. M. Shields,et al.  Identification and Characterization of a Gene Encoding a Gut-enriched Krüppel-like Factor Expressed during Growth Arrest* , 1996, The Journal of Biological Chemistry.

[42]  C. Lindquist,et al.  Recurrence of cranial base meningiomas. , 1996, Neurosurgery.

[43]  W. Lee.  Characterization of a newly established malignant meningioma cell line of the human brain: IOMM-Lee. , 1990, Neurosurgery.

[44]  J. Barnholtz-Sloan,et al.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016. , 2019, Neuro-oncology.

[45]  Jill S Barnholtz-Sloan,et al.  CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014 , 2017, Neuro-oncology.

[46]  K. Xie,et al.  Emerging role of KLF4 in human gastrointestinal cancer. , 2006, Carcinogenesis.

[47]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..